2024 Q2 Form 10-Q Financial Statement

#000149315224024329 Filed on June 18, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q2
Revenue $7.500M $1.733M $2.206M
YoY Change 239.99% 7.91% 3.27%
Cost Of Revenue $855.3K $983.1K $792.0K
YoY Change 7.99% 32.63% 3.26%
Gross Profit $1.439M $749.7K $1.414M
YoY Change 1.75% -13.29% 3.28%
Gross Profit Margin 19.18% 43.27% 64.1%
Selling, General & Admin $1.080M $1.159M $1.053M
YoY Change 2.59% 13.33% 0.64%
% of Gross Profit 75.09% 154.54% 74.48%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $173.0K $177.1K $168.2K
YoY Change 2.89% 2.68% -2.05%
% of Gross Profit 12.03% 23.62% 11.89%
Operating Expenses $2.116M $1.341M $2.020M
YoY Change 4.75% 13.84% 65.01%
Operating Profit $178.4K -$591.2K $186.3K
YoY Change -4.21% 88.71% 28.35%
Interest Expense $117.6K -$108.0K $90.03K
YoY Change 30.63% -13.32% -175.12%
% of Operating Profit 65.91% 48.33%
Other Income/Expense, Net $25.78K $13.73K $18.41K
YoY Change 40.06% 1574.39% 16632.73%
Pretax Income $86.60K -$685.4K $114.7K
YoY Change -24.47% 56.84% 351.39%
Income Tax $0.00 -$350.9K -$350.8K
% Of Pretax Income 0.0% -305.96%
Net Earnings -$148.6K -$93.01K $236.6K
YoY Change -162.78% -161.21% 25.78%
Net Earnings / Revenue -1.98% -5.37% 10.73%
Basic Earnings Per Share -$0.02 $0.03
Diluted Earnings Per Share -$0.02 -$0.01 $0.03
COMMON SHARES
Basic Shares Outstanding 9.024M shares 9.179M shares
Diluted Shares Outstanding 8.703M shares 9.011M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $437.3K $1.325M $1.704M
YoY Change -74.34% -37.23% -55.77%
Cash & Equivalents $437.3K $1.325M $1.704M
Short-Term Investments
Other Short-Term Assets $773.1K $310.9K $315.6K
YoY Change 144.98% 55.11% 195.21%
Inventory
Prepaid Expenses
Receivables $134.1K $112.0K $62.96K
Other Receivables $1.234M $1.234M $2.105M
Total Short-Term Assets $2.578M $2.982M $4.188M
YoY Change -38.43% -28.45% -13.26%
LONG-TERM ASSETS
Property, Plant & Equipment $7.029M $9.140M $7.150M
YoY Change -1.69% 26.78% -24.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.669M $1.634M $1.604M
YoY Change 4.05% 2.83% 15.9%
Other Assets
YoY Change
Total Long-Term Assets $12.71M $12.70M $12.82M
YoY Change -0.88% -1.2% -0.02%
TOTAL ASSETS
Total Short-Term Assets $2.578M $2.982M $4.188M
Total Long-Term Assets $12.71M $12.70M $12.82M
Total Assets $15.28M $15.68M $17.01M
YoY Change -10.13% -7.87% -3.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $816.0K $1.050M $803.5K
YoY Change 1.57% 1131.87% 0.51%
Accrued Expenses $25.85K $6.270K $24.61K
YoY Change 5.04% -47.79% 1237.5%
Deferred Revenue $1.500K
YoY Change -23.59%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $700.9K $700.9K $706.5K
YoY Change -0.79% -13.34% -14.81%
Total Short-Term Liabilities $1.543M $1.757M $1.535M
YoY Change 0.54% -3.0% -5.89%
LONG-TERM LIABILITIES
Long-Term Debt $8.955M $9.020M $9.207M
YoY Change -2.74% -2.59% -2.4%
Other Long-Term Liabilities $2.223M $2.249M $2.247M
YoY Change -1.06% -0.82% -1.13%
Total Long-Term Liabilities $11.18M $11.27M $11.45M
YoY Change -2.41% -2.24% -2.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.543M $1.757M $1.535M
Total Long-Term Liabilities $11.18M $11.27M $11.45M
Total Liabilities $12.72M $9.514M $12.99M
YoY Change -2.06% -28.67% 17.73%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $6.891M $7.039M $7.249M
YoY Change -4.94% 0.67%
Preferred Stock
YoY Change
Treasury Stock (at cost) $897.7K $872.2K $417.1K
YoY Change 115.23% 109.12%
Treasury Stock Shares
Shareholders Equity $5.993M $6.167M $6.831M
YoY Change
Total Liabilities & Shareholders Equity $15.28M $15.68M $17.01M
YoY Change -10.13% -7.87% -3.64%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q2
OPERATING ACTIVITIES
Net Income -$148.6K -$93.01K $236.6K
YoY Change -162.78% -161.21% 25.78%
Depreciation, Depletion And Amortization $173.0K $177.1K $168.2K
YoY Change 2.89% 2.68% -2.05%
Cash From Operating Activities -$459.4K -$79.33K $37.04K
YoY Change -1340.46% 29.54% -59.94%
INVESTING ACTIVITIES
Capital Expenditures $150.8K $160.8K $108.3K
YoY Change 39.28% 7.32% -315.16%
Acquisitions
YoY Change
Other Investing Activities -$35.00K -$15.00K -$15.00K
YoY Change 133.33% -91.43% -86.36%
Cash From Investing Activities -$185.8K -$175.8K -$123.3K
YoY Change 50.72% -45.88% -23.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$55.98K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$242.8K -324.2K -$320.8K
YoY Change -24.33% -7.25% -111.9%
NET CHANGE
Cash From Operating Activities -$459.4K -79.33K $37.04K
Cash From Investing Activities -$185.8K -175.8K -$123.3K
Cash From Financing Activities -$242.8K -324.2K -$320.8K
Net Change In Cash -$888.0K -579.3K -$407.1K
YoY Change 118.14% -21.25% -115.48%
FREE CASH FLOW
Cash From Operating Activities -$459.4K -$79.33K $37.04K
Capital Expenditures $150.8K $160.8K $108.3K
Free Cash Flow -$610.2K -$240.1K -$71.25K
YoY Change 756.44% 13.76% -149.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2024Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2024Q2 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2024 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2024Q2 IHT Interest On Notes Payable Related Party
InterestOnNotesPayableRelatedParty
usd
CY2023Q2 IHT Interest On Notes Payable Related Party
InterestOnNotesPayableRelatedParty
usd
CY2024Q2 IHT Operating Employee Retention Credit
OperatingEmployeeRetentionCredit
usd
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2024Q2 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
usd
CY2023Q2 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
usd
CY2024Q2 IHT Increase Decrease In Finance Lease Liability
IncreaseDecreaseInFinanceLeaseLiability
usd
CY2024Q2 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2024Q2 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
usd
CY2023Q2 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
usd
CY2024Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q2 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
470000 usd
CY2024Q1 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
470000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
25847 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6268 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1542808 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1756719 usd
CY2024Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
8954995 usd
CY2024Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
9019664 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2223225 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2249072 usd
CY2024Q2 us-gaap Liabilities
Liabilities
12721028 usd
CY2024Q1 us-gaap Liabilities
Liabilities
13025455 usd
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8988804 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8988804 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8773366 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8791822 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
6890505 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
7039055 usd
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
215438 shares
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
196982 shares
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
897731 usd
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
872238 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
5992774 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
6166817 usd
CY2024Q2 us-gaap Minority Interest
MinorityInterest
-3429377 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
-3511905 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2563397 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2654912 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15284425 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15680367 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2293970 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2205956 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
2115541 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
2019676 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
178429 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
186280 usd
CY2024Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
10667 usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
806 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
15112 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
17600 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
25779 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
18406 usd
CY2024Q2 IHT Interest On Mortgage Notes Payable
InterestOnMortgageNotesPayable
112321 usd
CY2023Q2 IHT Interest On Mortgage Notes Payable
InterestOnMortgageNotesPayable
83744 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2654912 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
86598 usd
CY2024Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
25493 usd
CY2024Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
152620 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2563397 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3682145 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3682145 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
465445 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
19760 usd
CY2023Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
149439 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4017911 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4017911 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
86598 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
465445 usd
CY2023Q2 IHT Operating Employee Retention Credit
OperatingEmployeeRetentionCredit
350791 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
19760 usd
CY2024Q2 us-gaap Depreciation
Depreciation
173042 usd
CY2023Q2 us-gaap Depreciation
Depreciation
168178 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22200 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-38775 usd
CY2024Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
462217 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
115155 usd
CY2024Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1150 usd
CY2023Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1530 usd
CY2023Q2 IHT Increase Decrease In Finance Lease Liability
IncreaseDecreaseInFinanceLeaseLiability
-815 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-233490 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-186831 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-459417 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
37036 usd
CY2024Q2 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
150826 usd
CY2023Q2 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
108290 usd
CY2024Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
35000 usd
CY2023Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
15000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-185826 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-123290 usd
CY2024Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
64669 usd
CY2023Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
44180 usd
CY2023Q2 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
27225 usd
CY2023Q2 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
100000 usd
CY2024Q2 IHT Payments To Minority Shareholder
PaymentsToMinorityShareholder
152620 usd
CY2023Q2 IHT Payments To Minority Shareholder
PaymentsToMinorityShareholder
149439 usd
CY2024Q2 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
25493 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-242782 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-320844 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-888025 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-407098 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1325368 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2111383 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
437343 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1704285 usd
CY2024Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zNVj0tKAexf1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86C_zBfeQf9pXLMb">USE OF ESTIMATES</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the audited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Trust’s operations are affected by numerous factors, including the economy, inflation, virus/pandemic, competition in the hotel industry and the effect of the economy on the travel and hospitality industries. The Trust cannot predict if any of the above items will have a significant impact in the future, nor can it predict what impact, if any, the occurrence of these or other events might have on the Trust’s operations and cash flows. Significant estimates and assumptions made by management include, but are not limited to, the estimated useful lives of long-lived assets and recoverability of long-lived assets and the fair values of the long-lived assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2024Q2 us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
3174041 shares
CY2024Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3185793 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3185793 shares
CY2024Q2 us-gaap Advertising Expense
AdvertisingExpense
79000 usd
CY2023Q2 us-gaap Advertising Expense
AdvertisingExpense
82000 usd
CY2024Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zVtgUPS7Gb0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_zhtgHz54Jbj4">CONCENTRATION OF CREDIT RISK</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit risk is the risk of an unexpected loss if a third party to a financial instrument fails to meet its contractual obligations. Financial instruments that potentially subject the Trust to a concentration of credit risk consist primarily of cash and cash equivalents. Management’s assessment of the Trust’s credit risk for cash and cash equivalents is low as cash and cash equivalents are held in financial institutions believed to be credit worthy. The Trust limits its exposure to credit loss by placing its cash with various major financial institutions and invests only in short-term obligations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While the Trust is exposed to credit losses due to the non-performance of its counterparties, the Trust considers the risk of this remote. The Trust estimates its maximum credit risk for accounts receivable at the amount recorded on the balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024 us-gaap Interest And Other Income
InterestAndOtherIncome
45000 usd
CY2024 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
45000 shares
CY2024Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
35000 usd
CY2024Q2 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
35000 shares
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
263125 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
274685 usd
CY2024Q2 IHT Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
7963082 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
9655916 usd
CY2024Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1192000 usd
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1204000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
646119 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
247906 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
260999 usd
CY2024Q2 IHT Shares Repurchase Price Per Share
SharesRepurchasePricePerShare
1.38
CY2023Q2 IHT Shares Repurchase Price Per Share
SharesRepurchasePricePerShare
0
CY2024Q2 us-gaap Interest Paid Net
InterestPaidNet
117000 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
88000 usd
CY2024Q2 IHT Notes Payables Shares Of Beneficial Interest And Partnership Units Repurchases
NotesPayablesSharesOfBeneficialInterestAndPartnershipUnitsRepurchases
0 usd
CY2023Q2 IHT Notes Payables Shares Of Beneficial Interest And Partnership Units Repurchases
NotesPayablesSharesOfBeneficialInterestAndPartnershipUnitsRepurchases
0 usd
CY2024Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
51000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
48000 usd
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
36309 usd
CY2024Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
1150 usd
CY2024Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2249072 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2223225 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P32Y
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0485 pure
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
100766 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
134367 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
134379 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
134391 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
134403 usd
CY2024Q2 IHT Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
3992855 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4631161 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2382089 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2249072 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
25847 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2223225 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
46000 shares
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
55200 usd
CY2024Q2 IHT Employee Retention Tax Credit Amount Received
EmployeeRetentionTaxCreditAmountReceived
1500000 usd
CY2024Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.02
CY2024Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.01
CY2023Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.01
CY2023Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.01
CY2023Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.01
CY2024Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.01
CY2024Q2 IHT Notes And Loans Receivable Net In Year Three
NotesAndLoansReceivableNetInYearThree
1925000 usd
CY2024Q2 IHT Notes Receivable Net Excluding Impairment
NotesReceivableNetExcludingImpairment
1925000 usd
CY2024Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5200000 usd
CY2024Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2100000 usd
CY2024Q2 IHT Syndications
Syndications
2900000 usd
CY2024Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1800000 usd
CY2024Q2 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
3300000 usd
CY2024Q2 us-gaap Compensation And Benefits Trust
CompensationAndBenefitsTrust
2700000 usd
CY2024Q2 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
the Trust conservatively placed an amount equal to approximately 12% of this total as a Tax Credit Receivable and Tax Refund on the Balance Sheet and Income statement, respectively, for the year ended January 31, 2024
CY2024Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
12190 shares
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
18216 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
203880 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2024Q2 us-gaap Revenues
Revenues
7500000 usd
CY2024 IHT Increase In Revenues Percentage
IncreaseInRevenuesPercentage
0.05 pure
CY2024 us-gaap Revenues
Revenues
7100000 usd
CY2024 IHT Non Cash Depreciation Expenses
NonCashDepreciationExpenses
956333 usd
us-gaap Revenues
Revenues
2900000 usd

Files In Submission

Name View Source Status
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
iht-20240430_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001493152-24-024329-index-headers.html Edgar Link pending
0001493152-24-024329-index.html Edgar Link pending
0001493152-24-024329.txt Edgar Link pending
0001493152-24-024329-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
iht-20240430.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
iht-20240430_cal.xml Edgar Link unprocessable
iht-20240430_def.xml Edgar Link unprocessable
iht-20240430_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed